Universal Health Services/$UHS
1D1W1MYTD1Y5YMAX
Capital at risk
About Universal Health Services
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.
- Ticker
- $UHS
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 89,950
- Headquarters
- King of Prussia, United States
- Website
- uhs.com
UHS Metrics
BasicAdvanced
$10B
7.20
$24.57
1.06
$0.80
0.45%
Price and volume
Market cap
$10B
Beta
1.06
52-week high
$246.33
52-week low
$140.08
Average daily volume
735K
Dividend rate
$0.80
Financial strength
Current ratio
1.116
Quick ratio
0.892
Long term debt to equity
0.577
Total debt to equity
0.687
Dividend payout ratio (TTM)
3.25%
Interest coverage (TTM)
12.96%
Profitability
EBITDA (TTM)
2,699.613
Gross margin (TTM)
44.61%
Net profit margin (TTM)
8.42%
Operating margin (TTM)
11.36%
Effective tax rate (TTM)
23.51%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
8.32%
Return on equity (TTM)
20.95%
Valuation
Price to earnings (TTM)
7.203
Price to revenue (TTM)
0.6
Price to book
1.41
Price to tangible book (TTM)
2.99
Price to free cash flow (TTM)
13.411
Free cash flow yield (TTM)
7.46%
Free cash flow per share (TTM)
13.197
Dividend yield (TTM)
0.45%
Forward dividend yield
0.45%
Growth
Revenue change (TTM)
10.05%
Earnings per share change (TTM)
29.66%
3-year revenue growth (CAGR)
9.50%
10-year revenue growth (CAGR)
6.75%
3-year earnings per share growth (CAGR)
36.62%
10-year earnings per share growth (CAGR)
13.34%
10-year dividend per share growth (CAGR)
7.18%
What the Analysts think about UHS
Analyst ratings (Buy, Hold, Sell) for Universal Health Services stock.
Analyst projections of the future price of Universal Health Services stock.
Bulls say / Bears say
Demand rebounded in the second quarter: same-facility acute-care adjusted admissions rose 2.9% and behavioural-health patient days 1.4%, while same-facility revenue grew 8.2% and 7.4% respectively. Management still guides to roughly 7% 2026 revenue growth and 6% adjusted EPS growth at the midpoint. (Universal Health Services, Fierce Healthcare)
The completed $835 million Talkspace acquisition adds about 6,000 clinicians and roughly $250 million of annual outpatient revenue. It gives UHS a virtual step-down route for patients and access to a broader, more commercially focused payer base; management expects the deal to be slightly accretive to adjusted earnings in its first year. (Stock Analysis, Healthcare Dive)
UHS is adding capacity in markets where it sees demand, with 177 new beds representing a 2.5% increase in same-facility capacity. If these beds and recently opened facilities ramp successfully, they provide room for future volume growth without relying only on price increases. (StockTitan, VectorShift)
UHS raised revenue guidance slightly but cut midpoint adjusted EBITDA by 1.9% and adjusted EPS by 2.6%; same-facility volume expectations fell to 1.5–2.5% for acute care and 1–2% for behavioural health. This points to slower volume momentum and weaker conversion of revenue into profit. (Fierce Healthcare, Universal Health Services)
Rising claims and professional fees are putting pressure on margins: UHS added $28 million to self-insured liability reserves in the second quarter and increased its full-year liability expense estimate by about $50 million. Management also expects professional-fee inflation of roughly 7–9%. (Last10K, Fierce Healthcare)
Coverage and reimbursement are becoming less predictable: exchange-market pressure is now expected to cost about $85 million in 2026 as people losing coverage shift towards uncompensated care, while Medicaid work requirements could create a further headwind in 2027. That matters because UHS is still exposed to Medicaid funding and patient volumes. (Investing.com, Behavioral Health Business)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.
UHS Financial Performance
Revenues and expenses
UHS Earnings Performance
Company profitability
Upcoming events
No upcoming events
UHS News
AllArticlesVideos
UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services' Directors and Officers for Breach of Fiduciary Duties – UHS
Business Wire2 months ago
Universal Health Services Q2 Earnings Call Highlights
MarketBeat2 months ago
Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty
Reuters2 months ago
Funds containing UHS
AllEURGBPUSD
Fund name | Fund size | $UHS weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.60% |
iShares S&P 500 Equal Weight€O4J0 | €4.3B | 0.21% |
iShares S&P 500 Equal Weight£EWSP | £3.7B | 0.21% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.15% |
iShares MSCI World Small Cap$WSML | $9B | 0.09% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.